123 related articles for article (PubMed ID: 28412998)
1. New hPSC-based human models to study pediatric Acute Megakaryoblastic Leukemia harboring the fusion oncogene RBM15-MKL1.
Ayllón V; Vogel-González M; González-Pozas F; Domingo-Reinés J; Montes R; Morales-Cacho L; Ramos-Mejía V
Stem Cell Res; 2017 Mar; 19():1-5. PubMed ID: 28412998
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
[TBL] [Abstract][Full Text] [Related]
3. Acute megakaryoblastic leukaemia with t(1;22)(p13·3;q13·1)/RBM15-MKL1 in an adult patient following a non-mediastinal germ cell tumour.
Saito Y; Makita S; Chinen S; Kito M; Fujino T; Ida H; Hosoba R; Tanaka T; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Miyagi-Maeshima A; Matsushita H; Izutsu K
Br J Haematol; 2020 Sep; 190(6):e329-e332. PubMed ID: 32572949
[No Abstract] [Full Text] [Related]
4. Detection of RBM15-MKL1 fusion was useful for diagnosis and monitoring of minimal residual disease in infant acute megakaryoblastic leukemia.
Takeda A; Shimada A; Hamamoto K; Yoshino S; Nagai T; Fujii Y; Yamada M; Nakamura Y; Watanabe T; Watanabe Y; Yamamoto Y; Sakakibara K; Oda M; Morishima T
Acta Med Okayama; 2014; 68(2):119-23. PubMed ID: 24743787
[TBL] [Abstract][Full Text] [Related]
5. Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene.
Torres L; Lisboa S; Vieira J; Cerveira N; Santos J; Pinheiro M; Correia C; Bizarro S; Almeida M; Teixeira MR
Pediatr Blood Cancer; 2011 May; 56(5):846-9. PubMed ID: 21370421
[TBL] [Abstract][Full Text] [Related]
6. Hemophagocytosis by leukemic megakaryoblasts in acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1.
Wiseman DH; Bonney DK; Wynn RF
J Pediatr Hematol Oncol; 2012 Oct; 34(7):576-80. PubMed ID: 22469944
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
8. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia.
Ma Z; Morris SW; Valentine V; Li M; Herbrick JA; Cui X; Bouman D; Li Y; Mehta PK; Nizetic D; Kaneko Y; Chan GC; Chan LC; Squire J; Scherer SW; Hitzler JK
Nat Genet; 2001 Jul; 28(3):220-1. PubMed ID: 11431691
[TBL] [Abstract][Full Text] [Related]
9. Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4 methyltransferase via a SPOC domain that is required for cytokine-independent proliferation.
Lee JH; Skalnik DG
PLoS One; 2012; 7(8):e42965. PubMed ID: 22927943
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations.
Lopez CK; Malinge S; Gaudry M; Bernard OA; Mercher T
Trends Cancer; 2017 Sep; 3(9):631-642. PubMed ID: 28867167
[TBL] [Abstract][Full Text] [Related]
11. TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia.
Langenberg-Ververgaert K; Renzi S; Fuligni F; Davidson S; Abdelhaleem M; Lo W; Malkin D; Shlien A; Shago M; Villani A; Abla O
Pediatr Blood Cancer; 2021 Jan; 68(1):e28542. PubMed ID: 32743872
[No Abstract] [Full Text] [Related]
12. RBM15-MKL1 (OTT-MAL) fusion transcript in an adult acute myeloid leukemia patient.
Hsiao HH; Yang MY; Liu YC; Hsiao HP; Tseng SB; Chao MC; Liu TC; Lin SF
Am J Hematol; 2005 May; 79(1):43-5. PubMed ID: 15849773
[TBL] [Abstract][Full Text] [Related]
13. RBM15 and MKL1 mutational screening in megakaryoblastic leukemia cell lines and clinical samples.
Kawaguchi H; Hitzler JK; Ma Z; Morris SW
Leukemia; 2005 Aug; 19(8):1492-4. PubMed ID: 15920491
[No Abstract] [Full Text] [Related]
14. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
Nakagawa K; Kuzumaki N
Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
[TBL] [Abstract][Full Text] [Related]
15. Acute megakaryoblastic leukemia with t(1;22)(p13.3;q13.1); RBM15-MKL1 mimicking hepatoblastoma in an infant: The role of karyotype in differential diagnosis.
Marques-Piubelli ML; Cordeiro MG; Cristofani L; Barroso RS; Paes VR; Castelli JB; Rodrigues Pereira Velloso ED
Pediatr Blood Cancer; 2020 Mar; 67(3):e28111. PubMed ID: 31802626
[No Abstract] [Full Text] [Related]
16. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F
Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462
[TBL] [Abstract][Full Text] [Related]
17. Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene.
Ishibashi M; Yokosuka T; Yanagimachi MD; Iwasaki F; Tsujimoto SI; Sasaki K; Takeuchi M; Tanoshima R; Kato H; Kajiwara R; Tanaka F; Goto H; Yokota S
Turk J Haematol; 2016 Dec; 33(4):331-334. PubMed ID: 27094503
[TBL] [Abstract][Full Text] [Related]
18. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
de Rooij JD; Hollink IH; Arentsen-Peters ST; van Galen JF; Berna Beverloo H; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Zimmermann M; Alonzo TA; Pieters R; Meshinchi S; van den Heuvel-Eibrink MM; Zwaan CM
Leukemia; 2013 Dec; 27(12):2280-8. PubMed ID: 23531517
[TBL] [Abstract][Full Text] [Related]
19. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities.
Cardin S; Bilodeau M; Roussy M; Aubert L; Milan T; Jouan L; Rouette A; Laramée L; Gendron P; Duchaine J; Decaluwe H; Spinella JF; Mourad S; Couture F; Sinnett D; Haddad É; Landry JR; Ma J; Humphries RK; Roux PP; Hébert J; Gruber TA; Wilhelm BT; Cellot S
Blood Adv; 2019 Nov; 3(21):3307-3321. PubMed ID: 31698461
[TBL] [Abstract][Full Text] [Related]
20. The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.
Mercher T; Raffel GD; Moore SA; Cornejo MG; Baudry-Bluteau D; Cagnard N; Jesneck JL; Pikman Y; Cullen D; Williams IR; Akashi K; Shigematsu H; Bourquin JP; Giovannini M; Vainchenker W; Levine RL; Lee BH; Bernard OA; Gilliland DG
J Clin Invest; 2009 Apr; 119(4):852-64. PubMed ID: 19287095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
